The store will not work correctly when cookies are disabled.
N-(6-Chloro-9H-beta-carbolin-8-yl)-4-methoxy-benzamide
ID: ALA78885
PubChem CID: 21362748
Max Phase: Preclinical
Molecular Formula: C19H14ClN3O2
Molecular Weight: 351.79
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)Nc2cc(Cl)cc3c4cc[nH]cc-4nc23)cc1
Standard InChI: InChI=1S/C19H14ClN3O2/c1-25-13-4-2-11(3-5-13)19(24)23-16-9-12(20)8-15-14-6-7-21-10-17(14)22-18(15)16/h2-10,21H,1H3,(H,23,24)
Standard InChI Key: VGRCMUSKMRUWMZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.0792 -0.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7417 -0.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3375 0.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2792 -0.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0292 -1.2750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4125 -0.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 0.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2250 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7250 0.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7792 1.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3333 -0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9792 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0333 -2.2292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7667 0.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0750 -0.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1333 -1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2167 -0.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4292 1.5208 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.4375 0.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6875 -0.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6333 0.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7125 1.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9958 0.9958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5125 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8000 0.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 4 1 0
6 2 1 0
7 3 2 0
8 5 1 0
9 4 2 0
10 3 1 0
11 8 1 0
12 9 1 0
13 8 2 0
14 17 1 0
15 11 2 0
16 11 1 0
17 6 2 0
18 12 1 0
19 20 1 0
20 16 2 0
21 15 1 0
22 7 1 0
23 19 1 0
24 22 2 0
25 23 1 0
7 6 1 0
10 12 2 0
14 24 1 0
21 19 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.79 | Molecular Weight (Monoisotopic): 351.0775 | AlogP: 4.58 | #Rotatable Bonds: 3 |
Polar Surface Area: 67.01 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.56 | CX Basic pKa: 3.50 | CX LogP: 4.12 | CX LogD: 4.12 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.57 | Np Likeness Score: -1.14 |
References
1. Castro AC, Dang LC, Soucy F, Grenier L, Mazdiyasni H, Hottelet M, Parent L, Pien C, Palombella V, Adams J.. (2003) Novel IKK inhibitors: beta-carbolines., 13 (14): [PMID:12824047] [10.1016/s0960-894x(03)00408-6] |